查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138416

全球血管损伤治疗市场-2022-2029

Global Vascular Injury Treatment Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球血管损伤治疗市场的增长取决于某些因素，例如随着血管损伤数量的增加，对血管损伤治疗的需求也在增加。随着交通事故、犯罪和伤害的增加，血管损伤的发生率也随之增加，对血管损伤的治疗提出了需求。国家对创新和医疗保健行业的支持有所增加，有助于促进业务扩张。

主要医疗保健提供商之间的合作预计将在预测期内推动全球血管损伤治疗市场

全球血管损伤治疗市场预计将在预测期内显着扩大，原因是与医院的合作伙伴关係不断增加，为心臟相关疾病提供临床护理。例如，Mayo Clinic Health System 和 OU Children's Hospital 于 2019 年合作开展了一项罕见的心脏病研究。 （左心发育不全综合征）。此外，我们正在与世界各地的许多医院合作，以解决罕见的心脏病。此外，我们还与五家左心发育不全综合征 (HLHS) 联盟成员合作：梅奥诊所、费城儿童医院、洛杉矶儿童医院、明尼苏达儿童医院和科罗拉多儿童医院。 Mayo Clinic Health System 于 2018 年与 Eko 合作开发数据驱动技术，以帮助医生识别潜在的高危心脏病。 Eko 和 Mayo Clinic 还宣布了构建和商业化基于机器的算法的计划，以帮助诊断患者的低射血分数（弱心臟泵）。因此，将出现更多检测心脏病的新技术，预计全球血管损伤治疗市场将在预测期内快速扩张。根据世界卫生组织 (WHO) 的数据，每年有 1790 万人死于心血管疾病。因此，预计在预测期内推动全球血管损伤治疗市场增长的原因之一是心血管疾病患病率的增加。

与血管治疗相关的高成本阻碍了血管损伤治疗市场的增长

然而，预计阻碍全球血管损伤治疗行业发展的主要原因之一是与血管疾病治疗相关的高成本。例如，与外周动脉疾病 (PAD) 相关的非冠状动脉手术的总费用为 729 美元。此外，降压治疗的平均费用为 313 美元，降脂治疗的平均费用为 207 美元。此外，根据美国心臟协会 (AHA) 的数据，到 2035 年，美国心血管护理的总成本预计将超过 1.1 万亿美元。

行业分析

全球血管损伤治疗市场根据波特五力分析、供应链分析、监管分析、定价分析、报销分析、未满足的需求和专利趋势等各种行业因素对市场进行了深入分析。 .

全球血管损伤治疗市场报告提供大约 40 多个市场数据表、45 多个图表和 180 页结构。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按伤病分类的市场细分
  • 按处理方法划分的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 对高级治疗的需求不断增加
    • 限制因素
      • 缺乏有效的治疗方法
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章受伤

  • 血栓形成
  • 挫伤/内膜瓣
  • 撕裂/撕裂
  • 抽搐
  • 动脉瘤和假性动脉瘤
  • 动静脉瘘 (AV)
  • 其他

第 8 章治疗

  • 修补血管成形术
  • 外侧前路椎板切开术/静脉切开术
  • 绕过移植
  • 血栓切除术
  • 解剖外径旁路
  • 其他

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 11 章公司简介

  • 克利夫兰诊所
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Massachusetts General Hospital
  • Heidelberg University Hospital
  • Royal Berkshire NHS Foundation Trust
  • Mayo Clinic Health System
  • Tenet Healthcare
  • Apollo Hospitals Enterprise Ltd.
  • Universal Health Services, Inc.
  • Mediclinic International
  • CHSPSC, LLC（*List Is Not Exhaustive）

第12章 重要考察

第13章 DataM

简介目录
Product Code: DMPH2589

Market Overview

Vascular Injury Treatment Market size was valued at US$ 3.04 billion in 2021 and is estimated to reach US$ 5.05 million by 2029, growing at a CAGR of 6.2% during the forecast period (2022-2029).

Vascular injury happens when a blood artery is damaged (artery and veins). In addition, vascular surgeons identify these injuries according to the type of wound that caused them, such as a blunt or penetrating injury. A blunt injury happens when a blood vessel is squeezed or crushed, while a penetrating injury occurs when a blood vessel is punctured, torn, or severed. Furthermore, a blunt or penetrating injury may result in a life-threatening hemorrhage. Blood clots can be severe if they break off and migrate to other areas of the body, such as the lungs and brain, resulting in ischemic strokes and pulmonary embolism. The most frequent cause of peripheral artery injury is blunt or penetrating damage to the extremities. These injuries, which damage the main arteries, nerves, and veins, may have negative impacts if they are not identified and handled immediately, leading to long-term injury and deformity.

Market Dynamics

The global vascular injury treatment market growth driven by certain factors such by the number of vascular injuries increases, so does the need for vascular injury care. When the number of traffic collisions, crime, and injuries increases, so does the incidence of vascular injury damage, providing a demand for vascular injury care. State support for innovation and the healthcare industry has been expanded, which has aided business expansion.

Partnerships between major healthcare providers, is expected to drive the global vascular injury treatment market during the forecast period

Owing to an increase in hospital partnerships to provide clinical treatments for heart-associated disorders, the global vascular injury care market is projected to expand significantly over the forecast period. For example, Mayo Clinic Health System and OU Children's Hospital partnered on rare heart disease research in 2019. (Hypoplastic Left Heart Syndrome). Furthermore, they are working with a wide number of hospitals around the world to combat rare heart disease. Furthermore, Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado partnered with five other Hypoplastic Left Heart Syndrome (HLHS) Consortium participants, including Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado. Mayo Clinic Health System has collaborated with Eko in 2018 to develop data-driven technologies that would assist doctors in identifying potentially risky heart diseases. Eko and Mayo Clinic have also announced plans to build and commercialize a machine-based algorithm that will assist in the diagnosis of low ejection fraction in patients (a weak heart pump). As a result, the global vascular injury treatment market is projected to expand at a faster pace over the forecast period as more new technology for detecting heart disease is launched. According to the World Health Organisation, 17.9 million people die each year from cardiovascular disease. As a result, one of the reasons projected to fuel growth in the global vascular injury care market over the forecast period is the growing prevalence of cardiovascular disease.

High cost associated with vascular treatment hampering the growth of the vascular injury treatment market

However, one of the main reasons projected to hinder the development of the global vascular injury care industry is the high cost associated with vascular disease treatment. For eg, the total cost of non-coronary procedures linked to peripheral artery disease (PAD) is US$ 729. Furthermore, the average cost of antihypertensive treatment is USD 313, while the average cost of lipid-lowering therapy is USD 207. Furthermore, according to the American Heart Association (AHA), the overall cost of cardiovascular care in the U.S. is expected to exceed USD 1.1 trillion by 2035.

Industry Analysis

The global vascular injury treatment market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, reimbursement analysis, unmet needs and patent trends etc.

Segment Analysis

The bypass graft segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The bypass graft segment continues significant dominance due to features such as elevated occurrence rates and health problems associated with vascular diseases. The most serious vascular diseases include stroke, arteriovenous malformation (AVM), peripheral artery disease (PAD), carotid artery disease (CAD), abdominal aortic aneurysm (AAA), pulmonary embolism, critical limb ischemia (CLI), deep vein thrombosis (DVT), varicose veins, and chronic venous insufficiency (CVI). According to the National Institutes of Health (NIH), coronary heart disease affects approximately 14 million men and women in the United States. It is most prominent in people over the age of 65. Plaque, a waxy material that accumulates blood to the heart muscle inside the lungs, induces the condition. The most effective treatment for artery damage is a bypass graft to enhance poor blood supply to the heart. Individuals with obstructive coronary artery disease, a type of ischemic heart disease, can benefit from this surgery because it decreases the risk of serious complications. As a result, demand for bypass grafts is growing, propelling market growth over the projected period.

Geographical Analysis

North America region holds the largest market share of the global vascular injury treatment market

Throughout the forecast period, North America is anticipated to continue its dominance in the overall vascular injury treatment market. During the forecast period, the growing prevalence of vascular diseases is projected to be the major factor driving the market's overall growth. Furthermore, the geriatric population in the United States is increasing, which is expected to increase the demand for peripheral vascular care in the region. According to the Centers for Disease Control and Prevention (CDC), about 8.5 million individuals in the United States suffer from peripheral artery disease, with 12 percent -20 percent of those above the age of 60 suffering from the disease. These are also some of the major reasons maintaining the region's dominance.

Competitive Landscape

The vascular injury treatment market is moderately competitive, owing to the presence of major market players in the key regions such as US, China, India and others. The key vascular injury treatment players which are contributing to the growth of the global market include Cleveland Clinic, Massachusetts General Hospital, Heidelberg University Hospital, Royal Berkshire NHS Foundation Trust, Mayo Clinic Health System, Tenet Healthcare, Apollo Hospitals Enterprise Ltd., Universal Health Services, Inc., Mediclinic International, CHSPSC, LLC among others.

Key Companies to Watch

Cleveland Clinic

Overview: Cleveland Clinic is a Cleveland, Ohio-based nonprofit clinical medical center. The Cleveland Clinic Foundation, a non-profit group founded in 1921 in Ohio, maintains and manages a 170-acre (69-hectare) complex in Cleveland, as well as 11 associated hospitals, 19 family health centers in Northeast Ohio, and hospitals in Florida and Nevada. Cleveland Clinic also runs two Cleveland Clinic Canada locations in Toronto and the Cleveland Clinic Abu Dhabi hospital outside of the United States.

Product Portfolio: Endovascular aneurysm repair (EVAR)- It is a minimally invasive aneurysm repair surgery. A surgeon makes a small incision in your groin and inserts a catheter (thin, flexible tube) into an artery.

The global Vascular Injury Treatment market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Injury
  • 3.2. Market Snippet by Treatment Methods
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing demand for advanced treatment methods
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of effective therapeutics
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Injury

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Segment
  • 7.3. Market Attractiveness Index, By Injury Segment
    • 7.3.1. Thrombosis
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Contusion/Intimal Flap
    • 7.3.3. Laceration/Transection
    • 7.3.4. Spasm
    • 7.3.5. Aneurysm and Pseudoaneurysm
    • 7.3.6. Arteriovenous (AV) Fistula
    • 7.3.7. Others

8. By Treatment Methods

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods Segment
  • 8.3. Market Attractiveness Index, By Treatment Methods Segment
    • 8.3.1. Patch Angioplasty
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Lateral Arteriorrhaphy/ Venorrhaphy
    • 8.3.3. Bypass Graft
    • 8.3.4. Thrombectomy
    • 8.3.5. Extraanatomic Bypass
    • 8.3.6. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Cleveland Clinic
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Massachusetts General Hospital
  • 11.3. Heidelberg University Hospital
  • 11.4. Royal Berkshire NHS Foundation Trust
  • 11.5. Mayo Clinic Health System
  • 11.6. Tenet Healthcare
  • 11.7. Apollo Hospitals Enterprise Ltd.
  • 11.8. Universal Health Services, Inc.
  • 11.9. Mediclinic International
  • 11.10. CHSPSC, LLC(*List Is Not Exhaustive)

12. Premium Insights

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us